Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ergosterol biosynthesis pathway is essential for fungal cell membrane integrity and is a crucial target for antifungal drugs. Ergosterol is the main sterol in fungal cell membranes, analogous to cholesterol in animal cells. Inhibition of ergosterol synthesis disrupts membrane function, leading to cell death or growth inhibition. Different enzymes in the pathway are targeted by different classes of antifungal agents.
Azoles inhibit lanosterol 14-alpha demethylase, a cytochrome P450 enzyme, which is essential for the conversion of lanosterol to ergosterol. Allylamines inhibit squalene epoxidase, an enzyme involved in the early steps of ergosterol synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ergosterol biosynthesis pathway.